Filing Flows › Core Laboratories (CLB) › Q3 2025
Core Laboratories (CLB) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 23, 2025
Core Laboratories (CLB) reported revenue of $135M for the third quarter 2025 (Q3 2025), +0.1% from a year earlier and +3% from the quarter before. Operating margin was 15.6%, net earnings $14.2M (10.6% of revenue).
Core Laboratories, Q3 2025: revenue $135M (+0.1% year over year), operating margin 15.6%, net earnings $14.2M, operating cash flow $8.5M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $135M | +3% | +0.1% |
| Operating profit | $20.9M | +37% | +6% |
| Net earnings | $14.2M | +34% | +21% |
| Operating cash flow | $8.5M | -39% | -35% |
| Free cash flow | $6.5M | — | — |
What changed
Revenue was $134.5M in Q3 2025, roughly flat year over year and up 3% from the previous quarter. Service was the largest line at 75% of revenue. Service added $2.3M year over year (up 2%), 1841% of the total change. Product declined 6%.
Operating profit was $20.9M, a 15.6% margin (up 0.8 points year over year). Of the extra revenue versus a year earlier, 907% reached operating profit, above the 15% margin then. Total costs fell 1% while revenue was flat. Net earnings were $14.2M, up 21% year over year. The effective tax rate was 20.5%.
Operating cash flow was $8.5M (down 35% year over year), 59% of net earnings. Non-cash charges added back $3.6M of depreciation and amortization and $1.3M of share-based compensation. Working capital and other items used $10.9M. After capital expenditures - operations ($2.0M), free cash flow as the company reports it was $6.5M.
Questions
What was Core Laboratories' revenue in the third quarter 2025?
Core Laboratories (CLB) reported revenue of $135M for the third quarter 2025 (Q3 2025), +0.1% from a year earlier and +3% from the quarter before.
Was Core Laboratories profitable in the third quarter 2025?
Operating profit was $20.9M (15.6% of revenue) and net earnings $14.2M.
Source: Core Laboratories 10-Q on SEC EDGAR.